Answers are grounded in this paper and cite their sources.
Theoretical analysis identifies novobiocin as a promising inhibitor of Plasmodium falciparum DNA helicase, suggesting new drug candidates.
Background: Plasmodium falciparum is a parasite (protozoa) of humans, & the lethal species of Plasmodium that affects malaria in humans. In the lack of a medically validated malaria vaccine, nearby are merely a few inexpensive medications available for therapy. Studies of diverse enzymes used in pharmaceutical drug discovery become essential aspects. The theoretical analysis helps to screen novel drug candidates.Methods: Here we have optimized three biologically active compounds, netropsin, nogalamycin, and novobiocin, and also carried out a molecular docking study with the protein ATP-dependent DNA helicase (UvrD) Plasmodium falciparum 3D7.Results: The plasmoDB id of the designated protein is PF3D7-0514100. Our calculations show that netropsin, nogalamycin, and novobiocin can have an affinity with the Plasmodium falciparum.Conclusion: Our study also predicted that novobiocin would give a better result with this protein than netropsin and nogalamycin. The frontier molecular orbitals & electrostatic potential (MEP) maps also support the higher activity of the novobiocin compound.
No takes yet. Share an insight, caveat, or question.
Mohammad Othman Alkurbi (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: